Active Implants Corporation

25 articles about Active Implants Corporation

• World’s First “Artificial Meniscus” Available in Israel

  11/18/2019

  Active Implants LLC, a company that develops orthopedic implant solutions, announced that two patients in Israel have undergone knee surgery for the company’s NUsurface® Meniscus Implant – the first “artificial meniscus” to be marketed in the Middle East.

• Final Patient Treated in Clinical Trials for Active Implants’ NUsurface® Meniscus Implant

  7/10/2018

  176 U.S. Patients Treated with First Artificial Meniscus in SUN and VENUS Trials

• 100th Patient Enrolled In Clinical Trials For Active Implants' Nusurface Meniscus Implant

  8/9/2017

• Active Implants Appoints Charles W. Federico And Gary D. Henley To Board

  7/12/2017

• Active Implants SUN Clinical Trial For Persistent Knee Pain Now Underway In San Diego

  6/7/2017

• Active Implants Locks in First Tranche of a $40 Million Equity Financing

  3/16/2017

• Active Implants Taps Wright Medical Technology Alum as New CEO

  2/22/2017

• Active Implants Corporation Release: Baton Rouge Orthopaedic Clinic Performs First Meniscus Replacement In The South With Nusurface Implant

  6/13/2016

• Active Implants Corporation Release: Salt Lake Regional Medical Center First In The U.S. To Perform Meniscus Replacement To Relieve Persistent Knee Pain In SUN Clinical Trial

  5/19/2016

• Active Implants Corporation Initiates Second Clinical Trial Evaluating NUsurface Meniscus Replacement

  2/2/2016

• Active Implants Corporation Release: VENUS Clinical Trial For Persistent Knee Pain Now Underway In Indiana

  11/24/2015

• Active Implants Corporation Release: VENUS Clinical Trial For Persistent Knee Pain Now Underway In New York City

  11/9/2015

• Active Implants Corporation Release: FDA Has Granted Investigational Device Exemption (IDE) Approval To Conduct A Pivotal Clinical Trial Of The Nusurface® Meniscus Implant For Early Knee Osteoarthritis

  5/29/2014

• Active Implants Corporation Closes $26.0 Million Financing Round

  9/3/2013

• Active Implants Corporation Release: NUsurface® Meniscus Clinical Trial Reaches Key Milestone

  1/7/2013

• Active Implants Corporation Appoints Giltaij as new CEO, Establishes International HQ in The Netherlands

  12/5/2012

• Orthopedic Company Active Implants Corporation Raises $10 Million

  1/11/2012

• Active Implants Corporation Announces Vice President Global Research & Development

  4/26/2010

• Active Implants Corporation Announces CE Class III Medical Device Approval

  9/1/2009

• Active Implants Corporation Names New Chief Financial Officer

  6/30/2009